Show simple item record

dc.contributor.authorChoonara, Faheema Ebrahim
dc.contributor.authorHaldorsen, Bjørg
dc.contributor.authorJanice, Jessin
dc.contributor.authorMbanga, Joshua
dc.contributor.authorNdhlovu, Isaac
dc.contributor.authorSaulosi, Osborne
dc.contributor.authorMaida, Tarsizio
dc.contributor.authorLampiao, Fanuel
dc.contributor.authorSimonsen, Gunnar Skov
dc.contributor.authorEssack, Sabiha Yusuf
dc.contributor.authorSundsfjord, Arnfinn
dc.date.accessioned2022-12-01T14:37:43Z
dc.date.available2022-12-01T14:37:43Z
dc.date.issued2022-09-14
dc.description.abstractThe global rise in infections caused by multidrug resistant (MDR) Enterobacterales poses a public health problem. We have performed a molecular epidemiological characterisation of representative plasmid-mediated AmpC (pAmpC) and ESBL-positive clinical isolates of Escherichia coli (n = 38) and Klebsiella pneumoniae (n = 17) from a tertiary hospital in Malawi collected in 2017. BlaCTX-M-15 was the most prevalent ESBL-determinant in E. coli (n = 30/38) and K. pneumoniae (n = 17/17), whereas blaCMY-2 was detected in nearly all AmpC-phenotype E. coli (n = 15/17). Whole genome sequencing revealed dominant globally disseminated E. coli sequence types (STs); ST410 (n = 16), ST131 (n = 7), and ST617 (n = 6). The ST distribution in K. pneumoniae was more diverse but included ST101 (n = 2), ST14 (n = 2), and ST340 (n = 2), all considered high-risk MDR clones. The isolates expressed an MDR profile, including resistance against commonly used antibiotics, such as fluoroquinolones, aminoglycosides, and/or trimethoprim-sulfamethoxazole, and harboured corresponding resistance determinants. Clonal analyses of the major STs of E. coli revealed closely related genetic clusters within ST410, ST131, and ST617 supporting within-hospital transmission between patients and/or via a common reservoir. The overall findings add to the limited knowledge on the molecular epidemiology of MDR E. coli and K. pneumoniae in Malawi and may help health policy makers to identify areas to target when addressing this major threat of antibiotic resistance.en_US
dc.identifier.citationChoonara, Haldorsen, Janice, Mbanga, Ndhlovu, Saulosi, Maida, Lampiao, Simonsen, Essack, Sundsfjord. Molecular Epidemiological Characterisation of ESBL- and Plasmid-Mediated AmpC-Producing Escherichia coli and Klebsiella pneumoniae at Kamuzu Central Hospital, Lilongwe, Malawi. Tropical Medicine and Infectious Disease. 2022;7(9)en_US
dc.identifier.cristinIDFRIDAID 2060755
dc.identifier.doi10.3390/tropicalmed7090245
dc.identifier.issn2414-6366
dc.identifier.urihttps://hdl.handle.net/10037/27661
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.relation.journalTropical Medicine and Infectious Disease
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0en_US
dc.rightsAttribution 4.0 International (CC BY 4.0)en_US
dc.titleMolecular Epidemiological Characterisation of ESBL- and Plasmid-Mediated AmpC-Producing Escherichia coli and Klebsiella pneumoniae at Kamuzu Central Hospital, Lilongwe, Malawien_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

Attribution 4.0 International (CC BY 4.0)
Except where otherwise noted, this item's license is described as Attribution 4.0 International (CC BY 4.0)